BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2015 5:56:00 PM | Browse: 1134 | Download: 1168
 |
Received |
|
2014-09-09 08:30 |
|
Peer-Review Started |
|
2014-09-09 14:44 |
|
To Make the First Decision |
|
2014-10-14 17:00 |
|
Return for Revision |
|
2014-10-15 17:18 |
|
Revised |
|
2014-10-27 14:21 |
|
Second Decision |
|
2014-11-11 09:39 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2014-11-19 09:11 |
|
Articles in Press |
|
2014-11-19 09:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-11-24 02:56 |
|
Typeset the Manuscript |
|
2015-01-26 18:25 |
|
Publish the Manuscript Online |
|
2015-02-11 17:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Management of patients with hepatitis B in special populations
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Evangelos Cholongitas, Konstantinos Tziomalos and Chrysoula Pipili |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Evangelos Cholongitas, Assistant Professor, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49 Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr |
| Key Words |
Hepatitis B; Antiviral therapy; Tenofovir; Entecavir; Telbivudine |
| Core Tip |
The management of hepatitis B virus (HBV) infection in special populations is reviewed. HBV patients with decompensated cirrhosis should receive nucleos(t)ides analogs (NAs) before and after liver transplantation. The choice of NA for patients with chronic kidney disease, renal transplant candidates and recipients depends on viremia levels, the severity of renal dysfunction and previous viral resistance. Children at the immune-active period may receive interferon or NAs. Pregnant women at risk of perinatal transmission should receive class B antiviral drugs or LAM. HBV patients receiving immunosuppressives should receive antiviral therapy based on HBV serological profile, HBV DNA detectability and intensity of immunosuppression. |
| Publish Date |
2015-02-11 17:56 |
| Citation |
Cholongitas E, Tziomalos K, Pipili C. Management of patients with hepatitis B in special populations. World J Gastroenterol 2015; 21(6): 1738-1748 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i6/1738.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i6.1738 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
